With regard to COVID-19 mRNA vaccine safety and efficacy: (a) has Health Canada reviewed the peer-reviewed, published scientific article by Hulscher N, Alexander P E., Amerling R, Gessling H, Hodkinson R, Makis W et al. titled “A Systematic Review Of Autopsy Findings In Deaths After COVID-19 Vaccination”, Science, Public Health Policy and the Law. 2024 Nov 17; v5.2019-2024; (b) what is Health Canada’s assessment of the study referred to in (a); (c) which department or agency makes the final determination about causality when a family member makes a vaccine injury death claim through the Vaccine Injury Support Program; (d) how many death claims relating to the COVID-19 vaccines have been made to the Vaccine Injury Support Program to date; (e) how many death claims relating to the COVID-19 vaccines have been accepted as being causally related; (f) how many death claims relating to the COVID-19 vaccines have been paid through the Vaccine Injury Support Program and what is that total amount paid out; (g) is an autopsy required in the case of a vaccine injury death claim; (h) if the answer to (f) is affirmative, what specialized immunohistochemistry is required to prove causation in the event of an mRNA vaccine injury death; (i) has Health Canada considered mandating autopsies with appropriate immunohistochemistry staining for sudden deaths; and (j) for the years 2019 to 2024, what is the excess all-cause mortality, broken down by year and reason for mortality?
In the House of Commons on September 15th, 2025. See this statement in context.